Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Updated June 2026 · ClinicalTrials.gov

University of Massachusetts, Worcester

Reviewed by TrialFinderData Editorial Team · Updated

9 clinical trials · 9 recruiting · OTHER

University of Massachusetts, Worcester has 9 clinical trials registered on ClinicalTrials.gov, with 9 actively recruiting participants. The trials listed below cover 14 conditions across the phases listed in the sidebar. Always discuss any specific trial with your physician before contacting a study site.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About University of Massachusetts, Worcester\'s Trial Portfolio

University of Massachusetts, Worcester is a non-industry sponsor (academic medical center, hospital, foundation, or research network). Non-industry sponsors often investigate novel approaches, rare conditions, and behavioral or surgical interventions that commercial sponsors may not prioritize.

9 of University of Massachusetts, Worcester's 9 registered trials are currently recruiting — roughly 100% of the portfolio. A high recruiting share usually points to an active research pipeline with multiple programs at the enrollment stage.

University of Massachusetts, Worcester's research footprint spans Schizophrenia (1 trials), Schizo Affective Disorder (1), and Alcohol Use Disorder (1) as the top three conditions. The full condition list, sorted by trial count, is in the sidebar.

Not Applicable is the largest single phase in University of Massachusetts, Worcester's portfolio at 78% of registered trials. The full phase breakdown appears in the sidebar.

Trials by University of Massachusetts, Worcester

RECRUITINGPhase 4NCT06174116

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

The main question this study is trying to answer is whether lumateperone, an FDA-approved antipsychotic drug, can help reduce possible side effects of clozapine, such as weight...

Sponsor: University of Massachusetts, WorcesterEnrolling: 501 location
SchizophreniaSchizo Affective Disorder
RECRUITINGNCT07269119

Piloting a Deaf Accessible Pre-Treatment for AUD

This pilot study will evaluate the feasibility, acceptability, and preliminary efficacy of an adaptation of Motivational Enhancement Therapy (MET) titled "DeafMET", intended for...

Sponsor: University of Massachusetts, WorcesterEnrolling: 301 location
Alcohol Use Disorder
RECRUITINGNCT06457139

Preventing T2DM After GDM With Immediate Postpartum Screening

The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies...

Sponsor: University of Massachusetts, WorcesterEnrolling: 1161 location
Gestational DiabetesType 2 Diabetes
RECRUITINGNCT06753669

Mothers' Action Project for Child Health

This randomized controlled trial will recruit Bangladeshi mothers and their young children into a 12 month intervention that provides child health and oral health education and...

Sponsor: University of Massachusetts, WorcesterEnrolling: 4601 location
Dental CariesObesity Risk
RECRUITINGNCT06388460

Asthma Link Effectiveness Trial

The goal of this cluster Randomized Control Trial is to determine the effectiveness of Asthma Link, a school supervised asthma therapy program, compared with an educational asthma...

Sponsor: University of Massachusetts, WorcesterEnrolling: 3501 location
Childhood Asthma
RECRUITINGNCT07072039

Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation

Chronic Obstructive Pulmonary Disease (COPD) is a serious lung condition that affects millions of people in the United States. Each year, it leads to about 150,000 deaths, nearly...

Sponsor: University of Massachusetts, WorcesterEnrolling: 501 location
COPD (Chronic Obstructive Pulmonary Disease)
RECRUITINGNCT06855329

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 months to...

Sponsor: University of Massachusetts, WorcesterEnrolling: 50013 locations
Progressive Pulmonary FibrosisInterstitial Lung Disease
RECRUITINGNCT07651761

Patient-Centered Practical Vaccine Talk For Busy Clinicians

The goal of this study is to assess the effect of an educational intervention for primary care providers (PCPs) on influenza and COVID-19 vaccine uptake among their adult patients...

Sponsor: University of Massachusetts, WorcesterEnrolling: 245001 location
InfluenzaCOVID-19
RECRUITINGNCT07153042

Sustainability and Precision Prevention Project

This is a five-year hybrid type 3 effectiveness-implementation study evaluating multilevel strategies to sustain a nationwide implementation of an evidence-based HIV prevention...

Sponsor: University of Massachusetts, WorcesterEnrolling: 37051 location
Sustainability

How to Approach a Trial Listing

Each trial card above links to a dedicated page with the official ClinicalTrials.gov data plus a plain-English translation of the eligibility criteria. We translate technical terminology (ECOG performance status, hepatic function values, exclusionary lab thresholds) into language that a patient or caregiver can understand, but the original clinical text and the live ClinicalTrials.gov record always govern any actual eligibility decision.

Before contacting a trial site, write down questions for your treating physician using the framework on our 25 Questions guide. Discuss whether the trial fits your treatment plan, what the time commitment looks like, and whether your insurance will cover the standard-of-care portions. Trials are not a substitute for a treatment plan — they are an addition that needs medical guidance to evaluate.

Authoritative Resources

Verify any trial registration directly on ClinicalTrials.gov. For background on the FDA approval pathway that Phase 3 trials feed into, see the FDA drug approval process. For cancer-specific trial guidance, the National Cancer Institute publishes patient-oriented overviews. For global trial registrations beyond the U.S., the WHO ICTRP aggregates registries from around the world.

Frequently Asked Questions

How many clinical trials does University of Massachusetts, Worcester have on ClinicalTrials.gov?

University of Massachusetts, Worcester has 9 clinical trials registered on the federal ClinicalTrials.gov registry, of which 9 are actively recruiting participants right now. These counts come directly from the ClinicalTrials.gov API and are updated as the registry changes.

What conditions does University of Massachusetts, Worcester study?

University of Massachusetts, Worcester's registered trials cover 14 conditions on ClinicalTrials.gov, led by Schizophrenia (1 trial), Schizo Affective Disorder (1 trial), Alcohol Use Disorder (1 trial), Gestational Diabetes (1 trial), Type 2 Diabetes (1 trial). The complete condition list appears in the sidebar of this page; each condition links to a page listing every recruiting trial in that area, regardless of sponsor.

How do I join a University of Massachusetts, Worcester clinical trial?

Joining a clinical trial is a medical decision that should always involve your treating physician. Each trial page on this site includes the eligibility criteria translated into plain English alongside the official clinical text, plus the contact information that the sponsor has registered with ClinicalTrials.gov. Bring the trial information to your doctor before reaching out — they can review the full inclusion and exclusion criteria against your medical history and help you decide whether to pursue screening.

What does the trial phase mean?

Phase 1 trials test safety and dosing in small groups (often 20–80 healthy volunteers or patients). Phase 2 trials evaluate efficacy and side effects in larger groups (100–300 patients with the target condition). Phase 3 trials confirm efficacy and monitor safety in the largest groups (300–3,000+ patients) and form the basis of an FDA approval submission. Phase 4 studies happen after a treatment is approved, monitoring long-term safety and effectiveness in real-world use. Some trials register without a phase — common for device, behavioral, or observational studies.

Where does this trial data come from?

All trial data is pulled directly from the ClinicalTrials.gov API v2, the official federal trial registry maintained by the National Library of Medicine at NIH. Under FDAAA 801, most U.S. drug and device trials are required to register, making ClinicalTrials.gov the most comprehensive source. Sponsors are responsible for keeping their listings current; trial status can shift between data refreshes.

How This Sponsor Page Is Built

Every count on this page is derived directly from ClinicalTrials.gov API v2 records. Trial counts include all trials currently registered to this sponsor; the recruiting count reflects trials with status "Recruiting" or equivalent. Plain-English eligibility translations on each linked trial page preserve the original clinical text alongside an accessible version. Read the full methodology for the data pipeline and limitations.

Source: ClinicalTrials.gov API v2, maintained by the National Library of Medicine at NIH. Public domain. Cite as: "TrialFinderData. Data: ClinicalTrials.gov."

Medical disclaimer: This page is informational, not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Last updated 2026-06-26 · 9 trials tracked for University of Massachusetts, Worcester.